Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 664, Issue 1-2, 2009, Pages 28-38

  Wu, Yasong ^a   Li, Ning ^a   Zhang, Tong ^a   Wu, Hao ^a   Huang, Chun ^a   Chen, Dexi ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Human hepatic cells HuH 7; Mitochondria; mtBER; Mutation; Stavudine (d4T)

Indexed keywords

ENDONUCLEASE; HYDROGEN PEROXIDE; MITOCHONDRIAL DNA; STAVUDINE;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; EXCISION REPAIR; GENE MUTATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER DEVELOPMENT; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOUTHERN BLOTTING;

ANTI-HIV AGENTS; BASE SEQUENCE; CELL LINE; DNA GLYCOSYLASES; DNA PRIMERS; DNA REPAIR; DNA, MITOCHONDRIAL; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-DIRECTED DNA POLYMERASE; HEPATOCYTES; HUMANS; HYDROGEN PEROXIDE; MOLECULAR SEQUENCE DATA; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; RNA, MESSENGER; STAVUDINE;

EID: 65049085523     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.02.006     Document Type: Article

References (51)

1. Squires K.E., et al. A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I). AIDS 14 11 (2000) 1591-1600
2. Ross L., et al. Thymidine-analog and multi-nucleoside resistance mutations are observed in both zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens. J. Hum. Virol. 4 4 (2001) 217-222
3. Bissuel F., et al. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy. J. Intern. Med. 235 4 (1994) 367-371
4. Miller K.D., et al. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann. Intern. Med. 133 3 (2000) 192-196
5. Miller R.F., et al. Herpes simplex virus type 2 encephalitis and concomitant cytomegalovirus infection in a patient with AIDS: detection of virus-specific DNA in CSF by nested polymerase chain reaction. Genitourin. Med. 71 4 (1995) 262-264
6. Gerschenson M., et al. Chronic stavudine exposure induces hepatic mitochondrial toxicity in adult Erythrocebus patas monkeys. J. Hum. Virol. 4 6 (2001) 335-342
7. Jones S.P., et al. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens. J. Acquir. Immune Defic. Syndr. 40 5 (2005) 565-572
8. Lim S.E., et al. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs. J. Mol. Biol. 329 1 (2003) 45-57
9. Lewis W., et al. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS 20 5 (2006) 675-684
10. Li J., et al. Beta-actin is required for mitochondria clustering and ROS generation in TNF-induced, caspase-independent cell death. J. Cell Sci. 117 Pt 20 (2004) 4673-4680
11. Velsor L.W., et al. Mitochondrial oxidative stress in human hepatoma cells exposed to stavudine. Toxicol. Appl. Pharmacol. 199 1 (2004) 10-19
12. Shadel G.S. Mitochondrial DNA, aconitase 'wraps' it up. Trends Biochem. Sci. 30 6 (2005) 294-296
13. Battey J., and Clayton D.A. The transcription map of mouse mitochondrial DNA. Cell 14 1 (1978) 143-156
14. Stuart J.A., et al. DNA base excision repair activities and pathway function in mitochondrial and cellular lysates from cells lacking mitochondrial DNA. Nucleic Acids Res. 32 7 (2004) 2181-2192
15. Graziewicz M.A., Longley M.J., and Copeland W.C. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem. Rev. 106 2 (2006) 383-405
16. Berneburg M., Kamenisch Y., and Krutmann J. Repair of mitochondrial DNA in aging and carcinogenesis. Photochem. Photobiol. Sci. 5 2 (2006) 190-198
17. Grishko V.I., et al. Contribution of mitochondrial DNA repair to cell resistance from oxidative stress. J. Biol. Chem. 280 10 (2005) 8901-8905
18. Wallace D.C. Mitochondrial DNA sequence variation in human evolution and disease. Proc. Natl. Acad. Sci. U.S.A. 91 19 (1994) 8739-8746
19. Wallace D.C., et al. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim. Biophys. Acta 1271 1 (1995) 141-151
20. Croteau D.L., et al. An oxidative damage-specific endonuclease from rat liver mitochondria. J. Biol. Chem. 272 43 (1997) 27338-27344
21. Beal M.F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6 5 (1996) 661-666
22. Ozawa T. Mitochondrial DNA mutations associated with aging and degenerative diseases. Exp. Gerontol. 30 3-4 (1995) 269-290
23. Stuart J.A., et al. Localization of mitochondrial DNA base excision repair to an inner membrane-associated particulate fraction. Nucleic. Acids Res. 33 12 (2005) 3722-3732
24. Chen D., et al. Upregulation of mitochondrial base-excision repair capability within rat brain after brief ischemia. J. Cereb. Blood Flow Metab. 23 1 (2003) 88-98
25. Chen D., et al. The p53 pathway promotes efficient mitochondrial DNA base excision repair in colorectal cancer cells. Cancer Res. 66 7 (2006) 3485-3494
26. Driggers W.J., et al. Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum group A cell line. Cancer Res. 56 6 (1996) 1262-1266
27. Chen D., et al. Age-dependent decline of DNA repair activity for oxidative lesions in rat brain mitochondria. J. Neurochem. 81 6 (2002) 1273-1284
28. Mambo E., et al. Electrophile and oxidant damage of mitochondrial DNA leading to rapid evolution of homoplasmic mutations. Proc. Natl. Acad. Sci. U.S.A. 100 4 (2003) 1838-1843
29. Chen D., et al. Detection of DNA base-excision repair activity for oxidative lesions in adult rat brain mitochondria. J. Neurosci. Res. 61 2 (2000) 225-236
30. Indo H.P., et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 7 1-2 (2007) 106-118
31. Pinz K.G., and Bogenhagen D.F. Characterization of a catalytically slow AP lyase activity in DNA polymerase gamma and other family A DNA polymerases. J. Biol. Chem. 275 17 (2000) 12509-12514
32. Lee H., Hanes J., and Johnson K.A. Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. Biochemistry 42 50 (2003) 14711-14719
33. Bai R.K., et al. Quantitative PCR analysis of mitochondrial DNA content in patients with mitochondrial disease. Ann. N.Y. Acad. Sci. 1011 (2004) 304-309
34. Berthet N., et al. Design of molecules that specifically recognize and cleave apurinic sites in DNA. J. Mol. Recogn. 7 2 (1994) 99-107
35. Lim S.E., and Copeland W.C. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J. Biol. Chem. 276 26 (2001) 23616-23623
36. Lewis W. Mitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathy. Prog. Cardiovasc. Dis. 45 4 (2003) 305-318
37. Lewis W. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antivir. Ther. 10 Suppl. 2 (2005) M13-M27
38. Copeland W.C., and Longley M.J. DNA polymerase gamma in mitochondrial DNA replication and repair. Sci. World J. 3 (2003) 34-44
39. Bohr V.A., and Anson R.M. Mitochondrial DNA repair pathways. J. Bioenerg. Biomembr. 31 4 (1999) 391-398
40. Ruiz-Pesini E., et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic. Acids Res. 35 (2007) D823-D828 (Database issue)
41. Schapira A.H. Mitochondrial disease. Lancet 368 9529 (2006) 70-82
42. Kohler J.J., and Lewis W. A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ. Mol. Mutagen. 48 3-4 (2007) 166-172
43. Casula M., et al. Infection with HIV-1 induces a decrease in mtDNA. J. Infect. Dis. 191 9 (2005) 1468-1471
44. Raidel S.M., et al. Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am. J. Physiol. Heart Circ. Physiol. 282 5 (2002) H1672-H1678
45. Allard J.P., et al. Effects of vitamin E and C supplementation on oxidative stress and viral load in HIV-infected subjects. AIDS 12 13 (1998) 1653-1659
46. Elbim C., et al. The role of phagocytes in HIV-related oxidative stress. J. Clin. Virol. 20 3 (2001) 99-109
47. Yakes F.M., and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 94 2 (1997) 514-519
48. Bohr V.A., Stevnsner T., and de Souza-Pinto N.C. Mitochondrial DNA repair of oxidative damage in mammalian cells. Gene 286 1 (2002) 127-134
49. Hashiguchi K., Bohr V.A., and de Souza-Pinto N.C. Oxidative stress and mitochondrial DNA repair: implications for NRTIs induced DNA damage. Mitochondrion 4 2-3 (2004) 215-222
50. Bienstock R.J., and Copeland W.C. Molecular insights into NRTI inhibition and mitochondrial toxicity revealed from a structural model of the human mitochondrial DNA polymerase. Mitochondrion 4 2-3 (2004) 203-213
51. Krishnan K.J., et al. What causes mitochondrial DNA deletions in human cells?. Nat. Genet. 40 3 (2008) 275-279